Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5397
-0.0556 %
$ 23 M
Market Cap
-3.17
P/E
ADAP - TOTAL LIABILITIES
Total Liabilities ADAP - Adaptimmune Therapeutics plc
243 M
LAST VALUE
-3.96%
2 YEAR CAGR
52.11%
5 YEAR CAGR
50.92%
10 YEAR CAGR